78411101 - METAPHORE PHARMACEUTICALS

Information

• Trademark
• 78411101

• Source

• Serial Number

  78411101

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  April 30, 2004
  20 years ago

• Transaction Date

  July 23, 2011
  13 years ago

• Status Date

  November 03, 2006
  17 years ago

• Location Date

  November 03, 2006
  17 years ago

• First Use Anywhere Date

  June 12, 2003
  21 years ago

• First Use In Commerce Date

  June 12, 2003
  21 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  SPRUILL, DARRYL M

• Attorney Docket Number

  60019610-036

  Attorney Name

  Belinda A. Boyer

  Law Office Assigned Location Code

  M30

• Owners

  • METAPHORE PHARMACEUTICALS, INC.

Case File Statements

• CC0000: The color(s) blue is/are claimed as a feature of the mark.
• D10000: "PHARMACEUTICALS"
• DM0000: The mark consists of Metaphore and arch design in the color blue. The color blue is claimed as a feature of the mark, and the color blue appears in the word Metaphore and in the arch design.
• GS0011: (Based on Intent to Use) Chemical, biochemical, biological, biotechnological products and preparations not including agarose, namely free radical and reactive oxygen species catalyst products, namely, compounds that mimic the catalytic activity of superoxide dismutase, intended for the pharmaceutical industry and for the sciences, other than for medical or veterinary use; chemical, biochemical, biological, biotechnological products not including agarose, namely free radical and reactive oxygen species catalyst products, namely, compounds that mimic the catalytic activity of superoxide dismutase for laboratory analyses, other than for medical or veterinary use; biochemicals namely, free radical and reactive oxygen species catalysts for in vitro use; biochemicals not including agarose namely, free radical and reactive oxygen species catalyst precursors for in vitro use; biochemicals not including agarose namely, free radical and reactive oxygen species catalyst metabolites for in vitro use; and chemical reagents not including agarose for scientific or research use
• GS0051: (Based on Intent to Use) Pharmaceutical preparations not including agarose for the treatment of pain, inflammation and inflammatory diseases, cancer, degenerative diseases including cartilage degeneration and nenrodegeneration, cardiovascular diseases, autoimmune diseases including arthritis, diseases of the skin and epidermis, ocular diseases, veterinary diseases; and chemotherapeutic preparations not including agarose for use in chemotherapy
• GS0421: (Based on Use in Commerce) Technical consultation and research in biology, pharmacology, biology, biotechnology, pharmacy, and medicine, namely consultation and research in the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose; providing information in the fields of biology, biotechnology, pharmacy, and medicine, namely providing information on the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose all for research and development purposes; research and development of new products for others in the fields of pharmacy, biology and biotechnology, medicine and the sciences, namely research and development for others in the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose; and laboratory research in the fields of biology, biotechnology, pharmacy, and medicine and the sciences, namely laboratory research in the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst precursors and catalyst metabolites not including agarose
• GS0441: (Based on Use in Commerce) Providing information in the fields of biology, biotechnology, pharmacy, and medicine, namely providing information on the biology, biotechnology, pharmacology and medicine of free radical and reactive oxygen species catalysts, catalyst constructs, catalyst precusors and catalyst metabolites not including agarose all for treatment and diagnosis purposes

Case File Event Statements

• 11/3/2006 - 17 years ago

  16 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 11/3/2006 - 17 years ago

  15 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 4/2/2006 - 18 years ago

  14 - CONTINUATION OF FINAL REFUSAL E-MAILED Type: GNCF

• 4/2/2006 - 18 years ago

  13 - ACTION CONTINUING A FINAL - COMPLETED Type: CNCF

• 2/15/2006 - 18 years ago

  12 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 1/30/2006 - 18 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/30/2006 - 18 years ago

  10 - PAPER RECEIVED Type: MAIL

• 7/28/2005 - 19 years ago

  9 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/28/2005 - 19 years ago

  8 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/26/2005 - 19 years ago

  7 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 6/7/2005 - 19 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/7/2005 - 19 years ago

  5 - FAX RECEIVED Type: FAXX

• 12/7/2004 - 19 years ago

  4 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/7/2004 - 19 years ago

  3 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/29/2004 - 19 years ago

  2 - ASSIGNED TO EXAMINER Type: DOCK

• 5/6/2004 - 20 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP